Increased aldosterone among HIV-infected women with visceral fat accumulation

AIDS

Volumn 23, Issue 17, 2009, Pages 2366-2370

  Lo, Janet ^a   Looby, Sara E D ^a   Wei, Jeffrey ^a   Adler, Gail K ^b   Grinspoon, Steven K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE URINE LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY COMPOSITION; BODY MASS; CARBOHYDRATE INTAKE; CD4+ T LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FAT INTAKE; FEMALE; GLUCOSE HOMEOSTASIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INTRAABDOMINAL FAT; LIPID STORAGE; LYMPHOCYTE COUNT; ORAL GLUCOSE TOLERANCE TEST; POTASSIUM INTAKE; PRIORITY JOURNAL; PROTEIN INTAKE; SODIUM INTAKE; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; URINE VOLUME; VIRUS LOAD;

ADULT; ALDOSTERONE; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INTRA-ABDOMINAL FAT;

EID: 70449344716     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283328d3b     Document Type: Article

References (14)

1. Ingelsson E, Pencina MJ, Tofler GH, Benjamin EJ, Lanier KJ, Jacques PF, et al. Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. Circulation 2007; 116:984-992.
2. Sowers JR, Whaley-Connell A, Epstein M. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150:776-783.
3. Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008; 19:88-90.
4. Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res 1999; 7:355-362.
5. Dolan SE, Hadigan C, Killilea KM, Sullivan MP, Hemphill L, Less RS, et al. Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr 2005; 39:44-54.
6. Rossi GP, Belfiore A, Bernini G, Fabris B, Caridi G, Ferri C, et al. Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endo-crinol Metab 2008; 93:2566-2571.
7. Bentley-Lewis R, Adler GK, Perlstein T, Seely EW, Hopkins PN, Williams GH, Garg R. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab 2007; 92:4472-4475.
8. FRAM Study Investigators. Fat distribution in women with HIV infection. J Acquir Immune Defic Syndr 2006; 42:562-571.
9. Nguyen A, Calmy A, Schiffer V, Bernasconi E, Battegay M, Opravil M, et al. Lipodystrophy and weight changes: data from the Swiss HIV Cohort Study, 2000-2006. HIV Med 2008; 9:142-150.
10. Guo C, Ricchiuti V, Lian BQ, Yao TM, Coutinho P, Romero JR, et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-gamma, and proinflammatory adipokines. Circulation 2008; 117:2253-2261.
11. Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 2007; 30:2349-2354.
12. Wada T, Ohshima S, Fujisawa E, Koya D, TsunekiH, Sasaoka T. Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipo-cytes. Endocrinology 2009; 150:1662-1669.
13. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langen-bach J, Willenberg HS, Barthel A, et al. Human adipocytes secrete mineralocorticoid- releasing factors. Proc Natl Acad Sci U S A 2003; 100:14211-14216.
14. Martinez E, Larrousse M, Gatell JM. Cardiovascular disease and HIV infection: host, virus, or drugs? Curr Opin Infect Dis 2009; 22:28-34